Search

Your search keyword '"Murayama, N."' showing total 1,129 results

Search Constraints

Start Over You searched for: Author "Murayama, N." Remove constraint Author: "Murayama, N."
1,129 results on '"Murayama, N."'

Search Results

351. Liver microsomal cytochrome P450 3A-dependent drug oxidation activities in individual dogs.

352. Novel cytochrome P450 1 (CYP1) genes in tree shrews are expressed and encode functional drug-metabolizing enzymes.

354. A Comprehensive Investigation of Dog Cytochrome P450 3A (CYP3A) Reveals a Functional Role of Newly Identified CYP3A98 in Small Intestine.

355. 2-Oxidation, 3-methyl hydroxylation, and 6-hydroxylation of skatole, a contributor to the odour of boar-tainted pork meat, mediated by porcine liver microsomal cytochromes P450 1A2, 2A19, 2E1, and 3A22.

356. Japanese school children's intake of selected food groups and meal quality due to differences in guardian's literacy of meal preparation for children during the COVID-19 pandemic.

357. Automated Bowel Sound and Motility Analysis with CNN Using a Smartphone.

358. Application of CYP1A2-Template System to Understand Metabolic Processes in the Safety Assessment.

359. Effect of quercetin glycosides on cognitive functions and cerebral blood flow: a randomized, double-blind, and placebo-controlled study.

360. Cytochrome P450 2J Genes Are Expressed in Dogs, Cats, and Pigs, and Encode Functional Drug-Metabolizing Enzymes.

361. Molecular and Functional Characterization of N -Acetyltransferases in Common Marmosets and Pigs.

362. [Management of healthy food environment improvement through restaurants and other settings by prefectures and cities of cabinet order].

363. Combined Risk Assessment of Food-derived Coumarin with in Silico Approaches.

364. Identifying Glucose Metabolism Status in Nondiabetic Japanese Adults Using Machine Learning Model with Simple Questionnaire.

365. A comprehensive analysis of six forms of cytochrome P450 2C (CYP2C) in pigs.

366. Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies.

367. Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2.

368. Newly identified tree shrew cytochrome P450 2B6 (CYP2B6) and pig CYP2B6b are functional drug-metabolising enzymes.

369. miR-144-3p/miR-451a promotes lymphovascular invasion through repression of PTEN/p19 in rectal neuroendocrine tumors.

370. Plasma NfL is associated with mild cognitive decline in patients with diabetes.

372. Characteristics of the glycometabolic categories based on the oral glucose tolerance test results in Japanese adults without diabetes.

373. Randomized, double-blind, crossover, placebo-controlled clinical trial to evaluate the effects of chicken hot water extract on insulin secretion.

374. Comparison of mouse and human cytochrome P450 mediated-drug metabolising activities in hepatic and extrahepatic microsomes.

375. Oxidation of 3'-methoxyflavone, 4'-methoxyflavone, and 3',4'-dimethoxyflavone and their derivatives having 5,7-dihydroxyl moieties by human cytochromes P450 1B1 and 2A13.

376. Convenience Food Options and Adequacy of Nutrient Intake among School Children during the COVID-19 Pandemic.

377. Effects of Socioeconomic Status on Nutrition and Nutrition Policy Studies in Asia.

378. Plasma Concentration Profiles for Hepatotoxic Pyrrolizidine Alkaloid Senkirkine in Humans Extrapolated from Rat Data Sets Using a Simplified Physiologically Based Pharmacokinetic Model.

379. Rapid Molecular Detection of Antifungal-Resistant Strains of Malassezia pachydermatis.

380. Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer.

381. Refined CYP2E1 ∗ Template ∗∗ system to decipher the ligand-interactions.

382. Validity of a selective recall method for assessing water intake and its relationship with hydration status.

383. Differences in Pharmacokinetics and Haematotoxicities of Aniline and Its Dimethyl Derivatives Orally Administered in Rats.

384. Molecular typing and antifungal drug susceptivity profile of Rhodotorula mucilaginosa from canine skin and ear canal.

385. Cost-of-illness study for axillary hyperhidrosis in Japan.

386. Speciation and separation of platinum(iv) polynuclear complexes in concentrated nitric acid solutions.

387. Roles of cytochrome P450 2A6 in the oxidation of flavone, 4'-hydroxyflavone, and 4'-, 3'-, and 2'-methoxyflavones by human liver microsomes.

388. Changes in Selected Food Groups Consumption and Quality of Meals in Japanese School Children during the COVID-19 Pandemic.

389. Hepatotoxicological potential of P -toluic acid in humanised-liver mice investigated using simplified physiologically based pharmacokinetic models.

390. Genetic variants of aldehyde oxidase (AOX) 1 in cynomolgus and rhesus macaques.

391. Prevalence of antimicrobial-resistant staphylococci in nares and affected sites of pet dogs with superficial pyoderma.

392. Metabolic Profiles of Tetrabromobisphenol A in Humans Extrapolated from Humanized-Liver Mouse Data Using a Simplified Physiologically Based Pharmacokinetic Model.

393. Deciphering Key Interactions of Ligands with CYP3A4-Template* system.

394. Liquid chromatography-tandem mass spectrometry analysis of oxidation of 2'-, 3'-, 4'- and 6-hydroxyflavanones by human cytochrome P450 enzymes.

395. The influence of ageism on stereotypical attitudes among allied health students in Japan: a group comparison design.

396. Metabolic activation and deactivation of dietary-derived coumarin mediated by cytochrome P450 enzymes in rat and human liver preparations.

397. Roles of human cytochrome P450 1A2 in coumarin 3,4-epoxidation mediated by untreated hepatocytes and by those metabolically inactivated with furafylline in previously transplanted chimeric mice.

398. Genetic variants of UDP-glucuronosyltransferases 1A1, 1A6, and 1A9 in cynomolgus and rhesus macaques.

399. Metabolic profiles for the pyrrolizidine alkaloid neopetasitenine and its metabolite petasitenine in humans extrapolated from rat in vivo and in vitro data sets using a simplified physiologically based pharmacokinetic model.

400. Different Hepatic Concentrations of Bromobenzene, 1,2-Dibromobenzene, and 1,4-Dibromobenzene in Humanized-Liver Mice Predicted Using Simplified Physiologically Based Pharmacokinetic Models as Putative Markers of Toxicological Potential.

Catalog

Books, media, physical & digital resources